Synopsis

Source of validity: Traditional
Rating (out of 5): 1

Pau d'arco (Tabebuia impetiginosa) is a tree native to South America, and its inner bark has a long history of use in traditional medicine, especially among indigenous peoples in Brazil and Argentina. Its use for urinary tract infections (UTIs) is rooted primarily in traditional practices rather than modern scientific validation. The bark contains compounds such as lapachol and beta-lapachone, which have demonstrated antimicrobial and antifungal properties in laboratory settings. This has led to the traditional use of pau d'arco for a variety of infections, including those affecting the urinary tract.

However, the clinical evidence supporting pau d’arco for UTIs is extremely limited. There are no high-quality human trials or systematic reviews that confirm its effectiveness or safety for this specific condition. Most of the available data come from in vitro studies, which show that extracts of pau d’arco can inhibit the growth of certain bacteria and fungi. These results do not necessarily translate to efficacy in humans, especially when considering bioavailability and dosing concerns. Furthermore, some of the active compounds, such as lapachol, have shown toxicity in animal studies.

In summary, while pau d’arco is sometimes used traditionally for the management of UTIs, its effectiveness has not been validated by rigorous scientific studies. Anyone considering its use should consult a healthcare professional, especially because of potential toxicity and lack of dosage standardization.

More about pau d'arco
More about Urinary Tract Infections

Other ingredients used for Urinary Tract Infections

Other health conditions supported by pau d'arco

Products containing pau d'arco